View More Recent Stories

Jul 22, 2024 12:04PM Goldman Sachs Reiterates Sell Rating on Ionis Pharmaceuticals (IONS)
Jul 22, 2024 07:03AM Ionis Pharmaceuticals (IONS) announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
Jul 16, 2024 08:06AM Jefferies Double Upgrades Ionis Pharmaceuticals (IONS) to Buy
Jun 27, 2024 08:12AM Ionis Pharmaceuticals (IONS) PT Raised to $53 at Stifel
Jun 25, 2024 06:55AM Ionis Pharmaceuticals (IONS) announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
Jun 24, 2024 02:08PM TD Cowen Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Jun 24, 2024 07:58AM Alnylam (ALNY) data is positive for Ionis (IONS), Intellia (NTLA) and negative for BridgeBio (BBIO) - analyst
Jun 18, 2024 07:04AM Ionis Pharmaceuticals (IONS) expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
Jun 17, 2024 06:22AM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
Jun 14, 2024 05:56AM Bernstein SocGen Group Upgrades Ionis Pharmaceuticals (IONS) to Market Perform
View More Recent Stories